Transcatheter Heart Valve Market: Size, Growth, Regional Analysis, And Market Analysis

Transcatheter Heart Valve Implantation:

Transcatheter heart valve implantation is a minimally invasive surgery that involves replacing damaged heart valves with bioprosthetic valves to treat valvular heart diseases, such as aortic stenosis and mitral regurgitation. It's a less invasive alternative to open-heart surgery, and it's especially beneficial for people who are at extremely high risk.


Market Analysis:

By 2024, the Transcatheter Heart Valve Market is expected to reach $6.60 billion, with a CAGR of 13.40 per cent. The rising desire for less intrusive procedures for high-risk patients, as well as the rising prevalence of mitral regurgitation and severe aortic stenosis condition, are driving the transcatheter heart valve replacement and repair market. 


Transcatheter heart valve devices are also being adopted due to quicker recovery times, shorter hospital stays, good outcomes with transcatheter prosthetic valve implantation, and technological developments. However, the high costs of transcatheter heart valves, the danger involved with the surgery, and some device-related issues such as manufacturer product recalls and mispositioning after implantation hamper the market growth.


One of the primary factors driving the growth of the Transcatheter Heart Valve Market is the increasing number of patients suffering from cardiovascular disease. Aortic valve dysfunction is caused by cardiovascular disorders, which increases the demand for an effective valve replacement operation. In addition, transcatheter aortic valve implantation is becoming more common as the prevalence of aortic stenosis rises.


Regional Analysis:

With a market share of more than 37.5 per cent, Europe dominated the Transcatheter Heart Valve Market, followed by North America. The rising prevalence of aortic stenosis and the availability of robust healthcare infrastructure are two main factors expected to drive the transcatheter aortic valve replacement system market in Europe to develop over the projected period. The senior population's high adoption rate of sophisticated transcatheter aortic valves will further contribute to the region's growth. The market is predicted to rise in the United States due to an increase in the incidence of aortic stenosis and favorable reimbursement policies.


Key Players:

Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), and TTK Healthcare Limited (India) are the major key players of the Transcatheter Heart Valve Market.

Comments

Popular posts from this blog

Significance of EHealth Software And Services

The OKR Software Market Is Estimated To Increase At A CAGR Of 12.60 Percent During The Forecast Period

Broadcast Switchers Market Report | the Demand for the Market Will Drastically Increase in the Future